Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-026106
Filing Date
2017-02-01
Accepted
2017-01-31 18:59:33
Documents
4
Period of Report
2017-03-21
Effectiveness Date
2017-02-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d280014ddef14a.htm DEF 14A 656968
2 GRAPHIC g280014001.jpg GRAPHIC 117023
3 GRAPHIC g280014002.jpg GRAPHIC 88671
4 GRAPHIC g280014003.jpg GRAPHIC 11233
  Complete submission text file 0001193125-17-026106.txt   957531
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-21898 | Film No.: 17562607
SIC: 2834 Pharmaceutical Preparations